National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH), USA

2016

  • 2017 ELASTIN; ELASTIC FIBERS & MICROFIBRILS GORDON RESEARCH CONFERENCE & GORDON RESEARCH SEMINAR(website)
  • A PHASE I STUDY OF THE SAFETY OF AAV2/8 LSPHGAA IN LATE-ONSET POMPE DISEASE(website)
  • ACCESSORY MEMBRANE AND INTRACELLULAR MEDIATORS IN BONE CELL MECHANOTRANSDUCTION(website)
  • ADDRESSING CRITICAL KNOWLEDGE GAPS IN EARLY DIFFUSE SCLERODERMA TRIAL DESIGN(website)
  • CELLULAR IMMUNOTHERAPY FOR SSC(website)
  • CHARACTERIZING THE TAKAYASU ARTERITIS GENETIC RISK IN RPS9/LILRB3(website)
  • CHROMATIN MODIFICATIONS THAT MODULATE DUX4 EXPRESSION IN FSHD(website)
  • COMPLEX 3-DIMENSIONAL IN VITRO HUMAN SKIN TISSUE MODELS FOR SCLERODERMA(website)
  • CONTRIBUTIONS OF IRF5 TO CHIKUNGUNYA VIRAL ARTHRITIS(website)
  • CORE 1: CLINICAL AND BIOLOGICAL SPECIMEN CORE(website)
  • CORE 2: LUNG TISSUE CORE(website)
  • CORE 3: TRANSLATIONAL GENOMICS AND DATA INTEGRATION CORE(website)
  • DIMETHYL FUMARATE IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION(website)
  • DISCOVERING NOVEL THERAPEUTICS FOR MYOTONIC DYSTROPHY TYPE 1 (DM1)(website)
  • EOSINOPHILS IN BULLOUS PEMPHIGOID(website)
  • EXPLORING THE ROLE OF FBXW7 IN REGULATING SATELLITE CELL FUNCTION AND SKELETAL MUSCLE REGENERATION(website)
  • GENETIC AND EPIGENETIC MECHAMISMS OF FSHD PATHOGENESIS(website)
  • GENETIC MODIFICATION OF IMMUNE CELLS TO IMPROVE MUSCLE REGENERATION(website)
  • GORDON CONFERENCE ON MYOGENESIS: ADVANCED MECHANISMS OF GROWTH AND REPAIR(website)
  • HORMONAL AND MOLECULAR ETIOLOGY OF SKELETAL ABNORMALITIES IN XLH(website)
  • IL-34 REGULATION OF CUTANEOUS IMMUNITY BY POLARIZING MYELOID CELL DIFFERENTIATION(website)
  • IMPAIRED BMP SIGNALING AND FAILED BONE FORMATION IN MUCOPOLYSACCHARIDOSIS VII(website)
  • INNATE IMMUNE ACTIVATION IN AUTOIMMUNE MYOPATHY(website)
  • INTERROGATING FUNCTIONAL AND MOLECULAR PROPERTIES OF PAX7+ PUTATIVE SKELETAL MUSCLE STEM/PROGENITOR CELLS DERIVED FROM HUMAN IPSCS OF HEALTHY DONORS AND DUCHENNE MUSCULAR DYSTROPHY PATIENTS(website)
  • INTERSECTION OF UPREGULATED BMP SIGNALING & CELLULAR MECHANOTRANSDUCTION IN FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP)(website)
  • MECHANISMS OF DUX4 MEDIATED FSHD PATHOLOGY(website)
  • MECHANISTIC AND THERAPEUTIC STUDIES OF AUTOSOMAL DOMINANT OSTEOPETROSIS(website)
  • MHC COMPLEMENT VARIANTS IN DISEASE SUSCEPTIBILITY OF IDIOPATHIC INFLAMMATORY MYOPATHIES(website)
  • MICROTUBULE REGULATED MECHANOTRANSDUCTION IN SKELETAL MUSCLE(website)
  • MODELING FSHD BY XENOGRAFTING HUMAN MYOGENIC PRECURSOR CELLS INTO MICE(website)
  • MONOCYTE AND MACROPHAGE POLARIZATION IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AND MACROPHAGE ACTIVATION SYNDROME.(website)
  • MOUSE MODELS FOR SYSTEMS THERAPEUTICS DEGENERATIVE DISEASES(website)
  • MULTIEXON SKIPPING TO RESTORE DYSTROPHIN PROTEIN EXPRESSION USING TETHERED RNPS(website)
  • MYOKINE FUNCTION OF MG53 IN MUSCLE INJURY-REPAIR AND REGENERATION(website)
  • MYONUCLEAR HOMEOSTASIS IN CRANIOFACIAL MUSCLES(website)
  • NASAL MICROBIOME AND HOST IMMUNITY IN GRANULOMATOSIS WITH POLYANGIITIS(website)
  • NITRIC OXIDE AND BONE HOMEOSTASIS IN PATIENTS WITH ARGININOSUCCINATE LYASE DEFICIENCY(website)
  • NOVEL MRI METHODS FOR OSTEOCHONDRITIS DISSECANS (OCD) / OSTEOCHONDROSIS (OC)(website)
  • NOVEL THERAPIES FOR DUCHENNE MUSCULAR DYSTROPHY(website)
  • NOVEL ZEBRAFISH MODELS FOR HUMAN FIBRODYSPLASIA OSSIFICANS PROGRESSIVA(website)
  • OPTIMIZING ELECTRICAL IMPEDANCE MYOGRAPHY OUTCOMES THROUGH DATA MINING(website)
  • PATHOGENESIS AND TREATMENT OF BONE DISEASE IN THE MUCOPOLYSACCHARIDOSES(website)
  • PROJECT 1: SYSTEMIC SCLEROSIS SKIN BIOMARKERS & THERAPEUTICS(website)
  • PROJECT 2: SCLERODERMA-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: THE ROLE OF THE OXIDANT STATE(website)
  • PROJECT 3: TARGETING PRO-FIBROTIC E3 LIGASES IN SYSTEMIC SCLEROSIS(website)
  • REGULATION OF SKELETAL GROWTH BY SOFT TISSUE EXTRACELLULAR MATRIX(website)
  • RESOURCE CORE(website)
  • RNA TOXICITY AND MUSCLE REGENERATION(website)
  • ROLE OF PHOSPORYLATED SOX9 IN SYSTEMIC SCLEROSIS PATHOGENESIS(website)
  • ROLES OF VOLTAGE SENSOR; S100A1 AND CALMODULIN IN SKELETAL MUSCLE CA2+ SIGNALING(website)
  • RPGRIP1L AND PKC BETA II IN DESMOGLEIN INTERNALIZATION(website)
  • SERUM EXOSOME MICRORNA IN SYSTEMIC SCLEROSIS(website)
  • SINGLE-NUCLEUS PROFILING OF FSHD HETEROGENEITY(website)
  • SMALL MOLECULE APPROACHES TO TARGETING THE DNA AND RNA IN MYOTONIC DYSTROPHY(website)
  • SPARING OF EXTRAOCULAR MUSCLES IN DUCHENNE MUSCULAR DYSTROPHY: A ROLE FOR A NOVEL MYOGENIC LINEAGE?(website)
  • SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE RESPONSE INDEX(website)
  • TARGETING DYSTROGLYCANOPATHIES USING PLURIPOTENT-DERIVED MYOGENIC PROGENITORS(website)
  • TARGETING LEUKEMIA INHIBITORY FACTOR TO DYSTROPHIC MUSCLE VIA A MACROPHAGE-SPECIFIC TRANSGENE(website)
  • THE FUNCTION OF FKBP10 IN OSTEOGENESIS IMPERFECTA AND BRUCK SYNDROME(website)
  • UNCOVERING ANTIGENIC AND MICROBIAL CONTRIBUTORS TO THE PATHOGENESIS OF CUTANEOUS T CELL LYMPHOMA(website)

2016

  • A COMPREHENSIVE ATLAS OF TRANSCRIPTOME DIVERSITY IN MOUSE SKELETAL MUSCLE(website)
  • A MULTIPLEX ASSAY FOR EARLY DETECTION OF CUTANEOUS T-CELL LYMPHOMA(website)
  • BACTERIOPHAGE PRESENTING HYDROGELS TO TREAT OSTEOMYELITIS(website)
  • COMPARISON OF METHOTREXATE AND BIOLOGICS IN JIA (COMPARE-JIA)(website)
  • CONTRIBUTION OF ADIPOCYTES AND ADIPOSE SECRETED FACTORS TO FIBROSIS IN SYSTEMIC SCLEROSIS(website)
  • CORE 1: MUSCULAR DYSTROPHY CELL AND SERUM BANKING CORE(website)
  • CORE 2: THERAPEUTIC VIRAL VECTOR DESIGN AND DEVELOPMENT CORE(website)
  • CREB3L1 IS NECESSARY FOR BONE DEVELOPMENT AS EVIDENCED BY MUTATIONS THAT CAUSE OSTEOGENESIS IMPERFECTA(website)
  • CRISPR/CAS9-BASED GENE EDITING FOR THE CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY(website)
  • DEVELOPMENT OF A NOVEL BIOLOGIC MEDICAL PRODUCT FOR DYSKERATOSIS CONGENITA(website)
  • DIFFERENTIAL INDUCTION AND ANTIMICROBIAL FUNCTION OF INTERFERONS IN LEPROSY(website)
  • DRUGS; GERMS; AND JOINTS: ANTIBIOTICS; GUT MICROBIOTA; AND JUVENILE IDIOPATHIC ARTHRITIS(website)
  • EMERIN REGULATION OF MOLECULAR PATHWAYS: IMPLICATIONS FOR MUSCLE DISEASE(website)
  • ENGINEERING A BIOMATERIAL NICHE OF SATELLITE CELLS FOR SKELETAL MUSCLE REGENERATION(website)
  • ENHANCING MYOBLAST FUSION IN MUSCULAR DYSTROPHY(website)
  • ERRGAMMA AGONISTS TO TREAT MUSCULAR DYSTROPHY(website)
  • ESTABLISHING AN FSHD-LIKE MOUSE FOR THERAPEUTIC DEVELOPMENT(website)
  • GENETIC REPAIR OF MUSCULAR DEGENERATION ASSOCIATED WITH DUCHENNE MUSCULAR DYSTROPHY(website)
  • GENOMICS OF VARIABILITY IN PROGRESSION AND SEVERITY OF SKIN FIBROSIS(website)
  • IDENTIFICATION OF NOVEL REGULATORS GOVERNING OSTEOCLAST-OSTEOBLAST COUPLING(website)
  • INNOVATIVE APPROACHES TO TREAT DUCHENNE MUSCULAR DYSTROPHY USING IPSC-DERIVED MUSCLE PROGENITORS(website)
  • INTERFERON INDUCIBLE GENE PROGRAMS IN LEPROSY(website)
  • MARFAN AORTIC EMBRYOLOGIC ORIGIN INFLUENCES MIR-29B REGULATORS AND TARGETS(website)
  • MECHANISMS OF DESMOSOME REGULATION AND DISASSEMBLY IN THE SKIN DISEASE PEMPHIGUS(website)
  • MECHANISTIC AND THERAPEUTIC INVESTIGATIONS OF SCLERODERMA(website)
  • MECHANOSIGNALING FUNCTIONS OF THE DYSTROPHIN GLYCOPROTEIN COMPLEX IN MUSCULAR DYSTROPHY(website)
  • MG53-MEDIATED MEMBRANE REPAIR IN MUSCLE PHYSIOLOGY AND DISEASE(website)
  • MODELING MUSCLE WASTING IN CANCER CACHEXIA(website)
  • MOLECULAR AND THERAPEUTIC MECHANISMS OF A NEW MODEL OF CONGENITAL MUSCULAR DYSTROPHY(website)
  • MR ASSESSMENT OF BIOENERGETICS AND MICROVASCULAR FUNCTION IN DYSTROPHIC MUSCLE(website)
  • MRI-BASED COMPUTER MODELS OF DMD GAIT TO EXPLAIN SELECTIVE MUSCLE DEGENERATION(website)
  • MULTISCALE MODELING FOR TREATMENT DISCOVERY IN DUCHENNE MUSCULAR DYSTROPHY(website)
  • MUSCLE TREGS IN HEALTH AND DISEASE(website)
  • MUSCLE-SPECIFIC REGULATION OF PABPN1 EXPRESSION(website)
  • MYOGENESIS AND RNA BIOGENESIS IN A MOUSE MODEL OF OPMD(website)
  • NOVEL THERAPIES FOR INHERITED MUSCLE DISEASES(website)
  • NUPR1 IS A NOVEL TARGET IN BONE METABOLISM(website)
  • OSTEOLYTIC CONVERSION OF INFLAMMATORY MACROPHAGES(website)
  • PAK1 ACTIVATION REDUCES MUSCULAR DYSTROPHY-MEDIATED FIBROSIS(website)
  • PATHOGENIC MECHANISMS IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY(website)
  • PROJECT 1: PRECLINICAL DEVELOPMENT OF SURROGATE GENE THERAPY USING GALGT2(website)
  • PROJECT 2: DUX4 INHIBITION WITH NON-CODING RNAS AS A THERAPEUTIC STRATEGY FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD)(website)
  • R16/17-INDEPENDENT NNOS ANCHORING MECHANISM(website)
  • REGULATION OF MACROPHAGE ACTIVATION AND INFLAMMATION IN SCLERODERMA(website)
  • REGULATION OF MITSUGUMIN 29 EXPRESSION IN MUSCLE PHYSIOLOGY AND DISEASES(website)
  • RESPIRATORY MUSCLE TRAINING IN LATE-ONSET POMPE DISEASE(website)
  • ROLE OF PTP4A1 IN SYSTEMIC SCLEROSIS(website)
  • ROLE OF SARCOSPAN IN CELL SURFACE EXPRESSION OF LAMININ-BINDING COMPLEXES(website)
  • ROLE OF THE FANCONI ANEMIA DNA REPAIR PATHWAY IN EPIDERMAL STEM AND PROGENITOR CELLS(website)
  • SARCOLIPIN IN DUCHENNE MUSCULAR DYSTROPHY(website)
  • STUDY OF SKELETAL MUSCLE DIFFERENTIATION IN HUMAN IPS CELLS BY KNOCK-IN REPORTERS(website)
  • SYSTEMIC SCLEROSIS (SSC) VASCULOPATHY: IMPROVED CLINICAL MONITORING AND TREATMENT(website)
  • THE CYTOSOLIC NUCLEIC ACID-SENSING PATHWAY AND SKIN ANTIVIRAL INNATE IMMUNITY(website)
  • THE ROLE OF P38K AND PROTEIN HOMEOSTASIS IN LIMB-GIRDLE MUSCULAR DYSTROPHIES(website)
  • THE SARCOGLYCAN COMPLEX IN SKELETAL MUSCLE MECHANOTRANSDUCTION(website)
  • TNF-ALPHA BLOCKADE WITH CERTOLIZUMAB TO PREVENT PREGNANCY COMPLICATIONS IN HIGH-RISK PATIENTS WITH APS(website)
  • TRANSCRIPTIONAL NETWORKS IN THE IMMUNE RESPONSE TO LEPROSY(website)
  • TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY WITH THE MUSCLE CALCIUM PUMP(website)
  • VASCULITIS AND TRANSLATIONAL MEDICINE(website)
  • VITAMIN D METABOLISM IN LEPROSY(website)

2015

  • A C. ELEGANS DRUG DISCOVERY PLATFORM FOR DYSFERLIN-BASED MUSCULAR DYSTROPHIES(website)
  • A MULTIPLEX ASSAY FOR THE DIAGNOSIS OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS(website)
  • A NOVEL APPROACH TO OSTEOGENESIS IMPERFECTA_ THE COLLAGEN PROTEIN FOLDING PROBLEM(website)
  • ADIPOKINE MODULATION OF FIBROSIS: NOVEL SCLERODERMA PATHWAY(website)
  • ANALYSIS OF D4Z4 HETEROCHROMATIN IN FSHD MYOBLAST MODELS(website)
  • ANTI TNF-ALPHA APPROACH TO TREAT OSTEOGENESIS IMPERFECTA(website)
  • ASSESSING AND MODULATING INFLAMMATION AND FIBROSIS IN DYSTROPHIC MUSCLE(website)
  • CHAPERONE DYSFUNCTION IN MYOPATHY: CONNECTING YEAST GENETICS WITH MOUSE MODELS(website)
  • CHARACTERIZING IN SITU T CELL:DENDRITIC CELL NETWORKS IN HUMAN LUPUS NEPHRITIS AND RENAL ALLOGRAFT REJECTION(website)
  • DEVELOPMENT AND HOMEOSTASIS OF SKELETAL MUSCLE IN HEALTH AND DISEASE(website)
  • DEVELOPMENT OF A NOVEL HIBM2 MOUSE MODEL AND THERAPY(website)
  • DOWN-REGULATION OF MICRORNA-206 IN STRIATED MUSCLE OF MDX MICE IMPROVES MUSCLE FUNCTION.(website)
  • EFFECT OF ATORVASTATIN ON ENDOTHELIAL FUNCTION AND RAYNAUD IN DIFFUSE SCLERODERMA(website)
  • EFFECTIVENESS OF VBP15; A DISSOCIATIVE STEROIDAL ANALOGUE; ON INFLAMMATION IN A MOUSE MODEL OF ARTHRITIS(website)
  • ENGINEERING DISEASE-SPECIFIC T CELLS FOR PEMPHIGUS THERAPY(website)
  • FIRST-IN-HUMAN RAAVRH74.MCK.GALGT2 DMD CLINICAL TRIAL(website)
  • FLMNB CAUSES PROGRESSIVE SKELETAL FUSIONS VIA TGF-BETA/BMP SIGNALING MODULATION(website)
  • HTS FOR SELECTIVE INHIBITORS OF MEPRIN ALPHA AND BETA(website)
  • IMAGING OF FAILED REGENERATION IN MUSCLES OF MUSCULAR DYSTROPHY PATIENTS(website)
  • IMMUNE CELLS AND CYTOKINES MEDIATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA(website)
  • IN VIVO GENE TARGETING TO TREAT INHERITED BONE DISEASE(website)
  • IN VIVO MOLECULAR PROBES FOR THE MEMBRANE REPAIR PATHWAY IN MUSCLE(website)
  • INNATE IMMUNE REGULATION OF STEM CELLS IN BONE FORMATION(website)
  • ION CHANNEL AND LIPID SCRAMBLASE FUNCTIONS OF ANOCTAMINS: ROLES IN MYOPATHY(website)
  • IRON THERAPY FOR AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS: A PILOT PROJECT(website)
  • LABORATORY OF ORAL CONNECTIVE TISSUE BIOLOGY(website)
  • LONGITUDINAL STUDIES FOR VASCULITIS(website)
  • MECHANISMS OF NUP210 REGULATION OF MUSCLE DEVELOPMENT AND REGENERATION(website)
  • MECHANOTRANSDUCTION AND THE REGULATION OF SKELETAL MUSCLE MASS(website)
  • MITIGATING MITOCHONDRIAL EPIGENETICS IN BONE REMODELING BY HYDROGEN SULFIDE(website)
  • MKP5 IN DYSTROPHIC MUSCLE DISEASE(website)
  • MOLECULAR ALTERATIONS CHARACTERIZING DISEASE PROGRESSION OF CUTANEOUS T CELL LYMPHOMA(website)
  • MOLECULAR AND CELLULAR DETERMINANTS OF ENTHESOPATHY IN X-LINKED HYPOPHOSPHATEMIA(website)
  • MOLECULAR BIOMARKERS OF IMPROVEMENT FOR PATIENTS WITH SYSTEMIC SCLEROSIS IN AN OPEN LABEL TRIAL OF MYCOPHENOLATE MOFETIL(website)
  • MUSCLE DISEASE UNIT(website)
  • NOVEL REGULATORS OF INFLAMMATORY ARTHRITIS AND BONE EROSION(website)
  • NUCLEAR MOVEMENT LINC COMPLEX AND EMERY-DREIFUSS MUSCULAR DYSTROPHY(website)
  • OPTIMIZATION OF AN INTEGRIN ENHANCING MOLECULE FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY(website)
  • REGULATION OF GASTRIC AND OSTEOCLAST ACIDIFICATION BY SNX10(website)
  • REGULATION OF HSCS AND HSC-DERIVED OSTEOBLASTS IN OSTEOGENESIS IMPERFECTA(website)
  • ROLES OF RNA HELICASE AND RIBOSOMAL BIOGENESIS IN NORMAL AND DISEASED MUSCLE(website)
  • SAFETY & SUITABILITY OF DABIGATRAN TO INHIBIT THROMBIN IN SCLERODERMA(website)
  • SPEG IS CRITICAL IN SKELETAL MUSCLE DEVELOPMENT AND FUNCTION(website)
  • TARGETING JANUS KINASES IN THE TREATMENT OF AUTOIMMUNE DISEASE(website)
  • TARGETING RAS GENE PATHWAYS IN PSORIATIC ARTHRITIS(website)
  • THE EFFICACY OF COMBINATION THERAPY IN OSTEOGENESIS IMPERFECTA(website)
  • THE IGE ANTIBODY RESPONSE TO DSG1 AND ENVIRONMENTAL ANTIGENS IN ENDEMIC PEMPHIGUS FOLIACEUS(website)
  • THE IMPACT OF CHILDHOOD CHRONIC DISEASE ON CHILD PATIENT REPORTED OUTCOMES(website)
  • TREATMENT OF MUSCULAR DYSTROPHY BY INCREASED ANGIOGENESIS(website)
  • UNDERSTANDING THE ROLE OF IFN-GAMMA AND CIITA IN SKELETAL MUSCLE(website)
  • UNVEILING THE PROTEOSTASIS NETWORK OF NORMAL AND DISEASE_CAUSING COLLAGEN_I(website)
  • USING THE DMD ZEBRAFISH ANIMAL MODEL FOR IDENTIFYING DRUG COMBINATION THERAPIES AND BIOMARKERS(website)
  • VBP15; AN INNOVATIVE STEROID-LIKE INTERVENTION ON DMD: VISION-DMD(website)
  • VCRC CLINICAL OUTCOMES PROGRAM(website)
  • VCRC PATIENT CONTACT REGISTRY RESEARCH PROGRAM(website)

2014

  • ADULT OUTCOMES OF JUVENILE IDIOPATHIC ARTHRITIS(website)
  • AN ANTIMICROBIAL-ELUTING BIORESORBABLE BONE FILLER FOR ORTHOPAEDIC APPLICATION(website)
  • ASSESSING AND MODULATING THE ROLE OF INFLAMMATION AND FIBROSIS IN THE DYSTROPHIC(website)
  • BIOINFORMATICS AND GENOMICS(website)
  • BONE ABNORMALITIES & HEALING DEFECT IN MUSCULAR DYSTROPHY(website)
  • Bone abnormalities & healing defect in muscular dystrophy
  • BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK(website)
  • DEFECTIVE C-MET SIGNALING IN AFRICAN AMERICAN SCLERODERMA PATIENTS(website)
  • DEFINING COMMON MECHANISMS OF AUTOIMMUNITY IN PEMPHIGUS VULGARIS(website)
  • DEVELOPMENT OF A STRENGTH TRAINING PROTOCOL IN DUCHENNE MUSCULAR DYSTROPHY(website)
  • DNA METHYLATION BIOMARKERS OF SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE(website)
  • ELUCIDATING MUSCLE REGENERATION DEFECTS IN FUKUTIN KO MICE(website)
  • ENGINEERING PLURIPOTENT STEM CELLS TO TREAT OSTEOGENESIS IMPERFECTA(website)
  • EPIGENETIC MODIFIERS OF D4Z4 IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD)(website)
  • EPIGENETIC REGULATION IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY TYPE 2 (FSHD2)(website)
  • GALECTIN 1: A NOVEL SMALL PROTEIN THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY(website)
  • GENETIC DISORDERS OF IMMUNODEFICIENCY AND INFLAMMATORY DISEASE(website)
  • GENETICS AND PATHOPHYSIOLOGY OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AND OTHER COMPLEX AUTOINFLAMMATORY DISEASES(website)
  • HIGHTHROUGHPUT SCREENING AND CELL REPOSITORY(website)
  • HUMAN ARTIFICIAL CHROMOSOME AS VECTORS FOR GENE THERAPY OF A MODEL SKIN DISEASE(website)
  • HUMAN DYSFERLIN AND ITS IMPLICATIONS IN LIMB-GIRDLE MUSCULAR DYSTROPHY(website)
  • IDENTICAL TWINS DISCORDANT FOR JUVENILE DERMATOMYOSITIS: IPSC-MYOGENIC CELLS(website)
  • IMAGING OF FAILED REGENERATION IN MUSCLES OF MUSCULAR DYSTROPHY PATIENTS(website)
  • IMMUNE CELL REGULATION OF THE REGENERATION OF DYSTROPHIC MUSCLE(website)
  • INHIBITION OF GSK3 BETA AS POTENTIAL THERAPY FOR DM1(website)
  • INHIBITION OF THE RHO/MRTF/SRF PATHWAY AS A NEW TREATMENT FOR SYSTEMIC SCLEROSIS(website)
  • INJURY RESPONSE IN NORMAL AND EDS TENDONS: REGULATORY ROLES OF COLLAGEN V(website)
  • INNATE IMMUNITY IN THE PATHOGENESIS OF LUPUS AND ANTIPHOSPHOLIPID VASCULOPATHY(website)
  • INTEGRATIVE ANALYSIS OF GENOMIC RISK FACTORS IN JUVENILE IDIOPATHIC ARTHRITIS(website)
  • INTRAFIBRILLAR MINERALIZATION VS. BONE FRAGILITY(website)
  • INVESTIGATOR DEVELOPMENT CORE(website)
  • LAMININ PROTEIN THERAPY FOR CONGENITAL MUSCULAR DYSTROPHY(website)
  • MANIPULATION OF PTEN/AKT SIGNALING IN DUCHENNE MUSCULAR DYSTROPHY AS A MEANS OF T(website)
  • MECHANISMS OF MACROPHAGE ACTIVATION AND FUNCTION IN SCLERODERMA(website)
  • Mechanisms of muscle inflammation in muscular dystrophy
  • MECHANISMS OF NUP210 REGULATION OF MUSCLE DEVELOPMENT AND REGENERATION(website)
  • MECHANISMS OF VERTEBRAL BONE DISEASE IN MUCOPOLYSACCHARIDOSIS VII(website)
  • MODULATING SKELETAL MUSCLE REGENERATION BY DELIVERY OF MYELOID LINEAGE CELLS(website)
  • MOLECULAR ETIOLOGY OF ENCHONDROMATOSIS: HEDGEHOG REGULATION IN CHONDROCYTES(website)
  • Molecular etiology of enchondromatosis: hedgehog regulation in chondrocytes
  • MUSCLE PHENOTYPING AND IMAGING(website)
  • NANOPATTERNED 3D VASCULARIZED FUNCTIONAL MUSCLE PATCH(website)
  • NON-HERITABLE GENETIC DISEASES OF THE SKELETAL SYSTEM: PATHOGENESIS AND TREATMENT(website)
  • NOVEL THERAPY FOR TUMOR-INDUCED OSTEOMALACIA(website)
  • PATHOBIOLOGY OF PBMC GENE EXPRESSION SIGNATURES IN POLYARTICULAR AND OLIGOARTICUL(website)
  • PATHOGENESIS AND NATURAL HISTORY IN A LONGITUDINAL HEMANGIOMA SYNDROME COHORT(website)
  • PATHOGENESIS OF SYSTEMIC SCLEROSIS: ROLE OF THE SKIN-RESIDENT CD8+ T CELLS(website)
  • PATHOGENESIS OF THE NEUROMUSCULAR SYNAPSE IN POMPE DISEASE(website)
  • PHYSIOLOGICAL ASSESSMENT CORE(website)
  • REGULATION OF MUSCLE FIBER TYPE AND RESISTANCE TO MUSCULAR DYSTROPHY(website)
  • REGULATION OF THE MELANOCYTE LINEAGE BY THE AP2 TRANSCRIPTION FACTOR FAMILY(website)
  • RELATIONSHIPS BETWEEN AUTOIMMUNE IGG1 AND IGG4 REPERTOIRES IN PEMPHIGUS VULGARIS(website)
  • ROLE OF DYSFERLIN IN T-TUBULES OF SKELETAL MUSCLE(website)
  • ROLE OF IRON AND HYPOXIA SENSING IN FGF23-DEPENDENT METABOLIC BONE DISEASE(website)
  • ROLE OF PROTEOGLYCAN SULFATION DURING MUSCLE REGENERATION IN DYSTROPHIC ANIMALS(website)
  • ROLE OF TRPV CHANNELS IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS VASCULOPATHY(website)
  • ROLE OF UNC-89 (OBSCURIN) IN SARCOMERE ASSEMBLY AND MAINTENANCE.(website)
  • SMCHD1 PATHWAYS AS CANDIDATE TARGETS FOR FSHD(website)
  • STAT3 AND IL-17-TH17 IN SKIN IMMUNITY TO MRSA(website)
  • STRUCTURE AND FUNCTION OF HUMAN PEMPHIGUS AUTOANTIBODIES(website)
  • STRUCTURE-FUNCTION OF THE NUCLEAR ENVELOPE BRIDGE AND ITS ROLE IN LAMINOPATHIES(website)
  • SYNOVIAL BIOMARKERS IN OLGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS(website)
  • TARGETED ENZYME REPLACEMENT THERAPY FOR RARE FORMS OF OSTEOGENESIS IMPERFECTA(website)
  • TARGETING THERAPEUTIC MOLECULES TO DYSTROPHIC MUSCLE VIA THE IMMUNE SYSTEM(website)
  • THE EFFECTIVENESS OF METHOTREXATE TO PREVENT EXTENSION OF EARLY LIMITED JIA(website)
  • THE ROLE OF GERMLINE MUTATIONS OF THE RAS/MAPK PATHWAY ON SKELETAL MYOGENESIS(website)
  • TRANSLATIONAL AND PRE-CLINICAL STUDIES OF AAV-MEDIATED GENE THERAPY OF MUSCULAR (website)
  • TREATMENT OF DERMATOMYOSITIS WITH AJULEMIC ACID; A NON-PSYCHOACTIVE CANNABINOID(website)
  • TSLP PROFIBROTIC SIGNALING AND ITS INTERACTION WITH TGF-BETA(website)
  • UNRAVELING THE MECHANISMS OF PRENATAL-ONSET DISORDERS AFFECTING THE SKELETON(website)
  • UTILITY OF NOVEL NA CHANNEL SLOW INACTIVATION ENHANCERS IN MYOTONIA(website)
  • VECTOR RESEARCH RESOURCE CORE(website)
  • VISUALIZING DESMOSOME STRUCTURE AND DYNAMICS BY POLARIZED FLUORESCENCE MICROSCOPY(website)

2013

  • 2013 COLLAGEN GORDON RESEARCH CONFERENCE AND GORDON RESEARCH SEMINAR(website)
  • A NOVEL MOUSE MODEL FOR IMMUNE-MEDIATED SKIN FIBROSIS IN SCLERODERMA(website)
  • ADAPTIVE IMMUNE RESPONSE TO GUT MICROBIOTA IN JUVENILE &ADULT SPONDYLOARTHRITIS (website)
  • ADVANCED THERAPIES IN JIA: TOWARD PREDICTIVE TREATMENT(website)
  • ASSESSING AND MODULATING THE ROLE OF INFLAMMATION AND FIBROSIS IN THE DYSTROPHIC(website)
  • CLINICAL PRIORITIZATION OF REPORTED DISEASE VARIANTS IN ASYMPTOMATIC INDIVIDUALS (website)
  • CLINICAL RESEARCH OF ORAL CONNECTIVE TISSUE PROGRAM(website)
  • CLINICAL TRIAL PLANNING IN POMPE DISEASE(website)
  • CO-FUND NIHLBI(website)
  • COLLIDER BIAS AND THE RISK FACTOR PARADOXES IN RHEUMATIC DISEASE RESEARCH(website)
  • COMPARATIVE EFFECTIVENESS OF THERAPEUTIC MODALITIES IN X-LINKED HYPOPHOSPHATEMIA(website)
  • CONSORTIUM FOR TRANSLATIONAL RESEARCH IN MARFAN SYNDROME(website)
  • CTCL IMMUNOBIOLOGY: LESSONS FROM ALEMTUZUMAB(website)
  • DEFECTIVE C-MET SIGNALING IN AFRICAN AMERICAN SCLERODERMA PATIENTS(website)
  • DEVELOPMENT OF A CLINICALLY RELEVANT OUTCOME MEASURE FOR FSHD THERAPEUTIC TRIALS(website)
  • DEVELOPMENT OF NOVEL UPPER EXTREMITY OUTCOME MEASURES USING 3D-VISION TECHNOLOGY(website)
  • DRUG DISCOVERY FOR MULTIPLE HEREDITARY EXOSTOSES (website)
  • DYSTROPHIC MOUSE COLONY AND FORCE ASSESSMENT(website)
  • ELUCIDATING MITOCHONDRIAL PATHOMECHANISMS OF ENT3 DISORDERS IN ENT3 KO MICE (website)
  • EVALUATION OF THE ANTIGENICITY OF BLACK RESTRICTED FVIII HAPLOTYPES AND HAPLOTYPE (website)
  • EXOME SEQUENCING IN THE SKELETAL DYSPLASIAS(website)
  • EXPLORING PERSPECTIVES ON GENOMICS AND SICKLE CELL PUBLIC HEALTH INTERVENTIONS (website)
  • FUNCTIONAL GENOMICS OF PSORIASIS(website)
  • GENOME CORRECTION OF MYOTONIC DYSTROPHY TYPE 1 IPS CELLS BY TALEN TECHNOLOGY(website)
  • GENOMIC REGULATION AT THE NUCLEAR PERIPHERY (website)
  • HIGHTHROUGHPUT SCREENING CORE(website)
  • IDENTIFICATION AND VALIDATION OF TARGETS OF PHENOTYPIC HIGH THROUGHPUT SCREENING (website)
  • IDENTIFICATION OF EARLY PSORIATIC ARTHRITIS(website)
  • IMAGING OF FAILED REGENERATION IN MUSCLES OF MUSCULAR DYSTROPHY PATIENTS(website)
  • INNOVATIVE EFFICACY MEASURES OF LUPUS NEPHRITIS THERAPIES (website)
  • INTERFERONS AND CYTOTOXIC LYMPHOCYTES IN DERMATOMYOSITIS AND CUTANEOUS LUPUS(website)
  • MAGNETIC RESONANCE IMAGING OF BOUND AND FREE WATER IN CORTICAL BONE(website)
  • MAPPING MODIFIERS OF CARDIOMYOPATHY UN MUSCULAR DYSTROPHY(website)
  • MECHANISMS OF DUX4 MEDIATED FSHD PATHOLOGY(website)
  • MECHANISMS OF MUSCLE INFLAMMATION IN MUSCULAR DYSTROPHY(website)
  • MODULATING THE LEVELS OF A SPLICING FACTOR TO REVEAL THE COMPLEXITIES OF A SPLICE
  • MODULATING THE LEVELS OF A SPLICING FACTOR TO REVEAL THE COMPLEXITIES OF A SPLICI(website)
  • MOLECULAR BASIS FOR SKELETAL MUSCLE PATHOPHYSIOLOGY IN POMPE’S DISEASE(website)
  • NATURALLY OCCURRING DOG MODEL FOR JUVENILE DERMATOMYOSITIS(website)
  • NOVEL REGULATION OF PTH RECEPTOR FUNCTIONS IN BONE(website)
  • NOVEL RHO KINASE INHIBITOR FOR SYSTEMIC SCLEROSIS(website)
  • ORCHESTRATION OF BREAST CANCER OSTEOLYTIC BONE METASTASIS BY MIF(website)
  • OVERCOMING OUR CLINICAL COMPLICATIONS: AAV VECTOR DESIGN FOR THE TREATMENT OF DMD(website)
  • PHOSPHOINOSITIDE SIGNALING REGULATES MELANOGENESIS(website)
  • PPAR-GAMMA’S ROLE IN ABERRANT ADIPOGENESIS AND FIBROSIS IN SYSTEMIC SCLEROSIS(website)
  • PREDICTIVE ABILITY OF GENE EXPRESSION SIGNATURES IN SKIN AS SSC BIOMARKERS(website)
  • REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY AT THE MYOTENDINOUS JUNCTION(website)
  • REGULATION OF THE MELANOCYTE LINEAGE BY THE AP2 TRANSCRIPTION FACTOR FAMILY(website)
  • REGULATORY T CELLS IN DUCHENNE MUSCULAR DYSTROPHY(website)
  • REPROGRAMMING AND DIRECTED DIFFERENTIATION OF SKELETAL MUSCLE CELLS FROM HPSCS (website)
  • ROLE OF LOCAL STRAIN IN OSTEOGENIC RESPONSE TO VIBRATION THERAPY IN HUMANS(website)
  • ROLES OF VOLTAGE SENSOR; S100A1 AND CALMODULIN IN SKELETAL MUSCLE CA2+ SIGNALING(website)
  • SCLERODERMA TWIN STUDY(website)
  • SCLERODERMA TWIN STUDY (website)
  • SKIN-TARGETED CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (website)
  • STRETCH DEPENDENT SIGNALING IN DYSTROPHIC SKELETAL MUSCLE(website)
  • STRUCTURAL MICROENVIRONMENT OF BONE MARROW STEM CELLS(website)
  • SYSTEMS BIOLOGY FOR MOLECULAR ANALYSIS OF TUBERCULOSIS IN ETHIOPIA (website)
  • TARGETED CORRECTION OF DOMINANT MUTATIONS OF TYPE I COLLAGEN CAUSING SEVERE OI(website)
  • TARGETED SMALL MOLECULE MEDICINAL CHEMISTRY FOR MYOTONIC DYSTROPHY-1 DRUG DEVELOP(website)
  • TARGETING THE LRP5 PATHWAY TO INCREASE BONE STRENGTH IN OSTEOGENESIS IMPERFECTA(website)
  • THE RELATIONSHIP BETWEEN GENOMIC VARIANTS AND MRI/MRS MARKERS IN DMD(website)
  • THE ROLE OF CMET IN SATELLITE CELLS DURING MUSCLE REGENERATION(website)
  • THE ROLE OF GUT AND SKIN MICROBIOME IN PSORIATIC ARTHRITIS(website)
  • THE ROLE OF IL-31 IN TH2 CYTOKINE-DRIVEN SYSTEMIC SCLEROSIS(website)
  • TNF-RECEPTORS AND PROGRAMMED CELL DEATH IN REGULATION OF AUTOIMMUNITY(website)
  • TNIP1 RISK HAPLOTYPES AND IMMUNE ENDOPHENOTYPES(website)
  • TNSALP MUTATIONS IN ATYPICAL FEMORAL FRACTURES WITH LONG-TERM BISPHOSPHONATE USE(website)
  • TRAINING AND EDUCATION CORE(website)
  • TRANSLATIONAL STUDIES OF GAA DEFICIENCY IN BIOENGINEERED HUMAN MUSCLE(website)
  • UNDERSTANDING THE SKELETAL PHENOTYPE OF GAUCHER DISEASE(website)
  • USING GENOMICS TO ELUCIDATE THE PATHOGENESIS OF GRANULOMATOSIS WITH POLYANGIITIS(website)

2012

  • MICROARRAY CORE(website)
  • 2013 INTERNATIONAL PACHYONYCHIA CONGENITA CONSORTIUM (IPCC) SYMPOSIUM(website)
  • A MYOUTUBE-SPECIFIC DELETION MODEL FOR SARCOPENIA (website)
  • A NEW DMD MODEL WITH A HUMANIZED GLYCOME(website)
  • ADVANCED THERAPIES IN JIA: TOWARD PREDICTIVE TREATMENT(website)
  • APPLYING BIOINFORMATICS TO RESEARCH IN IMMUNE; MUSCLE; AND BONE DISEASES(website)
  • ASSESSING AND MODULATING THE ROLE OF INFLAMMATION AND FIBROSIS IN THE DYSTROPHIC(website)
  • ASSESSING THE IMPACT OF OSTEOGENESIS IMPERFECTA ON NON-SKELETAL SYSTEMS(website)
  • ASSESSMENT OF BONE COMPOSITION THROUGH A NOVEL LIQUID/SOLID STATE MRI METHOD(website)
  • BECKER MUSCULAR DYSTROPHY: A NATURAL HISTORY STUDY TO PREDICT EFFICACY OF EXON SK(website)
  • BLOC-1 AND BLOC-2 FUNCTION IN MELANOSOME MATURATION(website)
  • CANCER, AUTOANTIGENS, AND SCLERODERMA INVESTIGATING THE CONNECTION (website)
  • CAVEOLIN-1 REGULATES MONOCYTE-FIBROCYTE LINEAGE CELL FUNCTIONS VIA CXCR4(website)
  • CCDC78 AND THE PATHOGENESIS OF CENTRONUCLEAR MYOPATHY(website)
  • CHARACTERIZATION OF AUTOREACTIVITY TO MUSCLE PROTEINS IN INCLUSION BODY MYOSITIS(website)
  • CHARACTERIZING THE CELLS OF ORIGIN FOR BASAL CELL CARCINOMA (website)
  • CO_FUND(website)
  • COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS (website)
  • CONGENITAL MUSCULAR DYSTROPHY: FROM CLINICAL PATHOLOGY TO UNDERLYING SCIENTIFIC M(website)
  • CORE D – PROTEOMIC AND CLINICAL CORE(website)
  • CORE E – MICROARRAY AND BIOINFORMATICS CORE(website)
  • CYTOPLASMIC ACTINS IN MAINTENANCE OF MUSCLE MITOCHONDRIA(website)
  • DEFECTIVE C-MET SIGNALING IN AFRICAN AMERICAN SCLERODERMA PATIENTS(website)
  • DETERMINANTS OF HEALTH RELATED QUALITY OF LIFE IN CHILDREN WITH JIA(website)
  • DEVELOPMENTAL BASIS OF ANEURYSM IN MARFAN SYNDROME AND THERAPEUTIC IMPLICATION(website)
  • DISEASE PATHOGENESIS AND MODIFICATION FOR CAV1.1-ASSOCIATED HYPOKALEMIC PERIODIC(website)
  • DRUGGABLE PATHWAYS REGULATING SELF-RENEWAL IN MUSCLE AND RHABDOMYOSARCOMA (website)
  • DUX4 AND THE P53 PATHWAY IN FSHD PATHOGENESIS(website)
  • DYSTROPHIC MOUSE COLONY AND FORCE ASSESSMENT(website)
  • ELUCIDATING THE CELLULAR AND MOLECULAR MECHANISMS OF LATE-ONSET SCOLIOSIS (website)
  • ENHANCING THE CARRA: INTEGRATION AND DISSEMINATION OF CLINICAL DATA(website)
  • ESTABLISHING ENDPOINTS IN CANINE MYOTUBULAR MYOPATHY FOR CLINICAL TRANSLATION(website)
  • EXERCISE AND BODY COMPOSITION IN JUVENILE IDIOPATHIC ARTHRITIS (website)
  • FIBROBLAST TGF-BETA/SIGNALING IN SCLERODERMA: MODULATION BY PPAR-GAMMA(website)
  • GENETIC AND GENOMIC DISSECTION OF PSORIATIC ARTHRITIS(website)
  • GENETIC METABOLIC MYOPATHY – ACID MALTASE DEFICIENCY(website)
  • GENETICALLY ENGINEERED MUSCLE STEM CELL TRANSPLANTATION FOR MUSCULAR DYSTROPHY (website)
  • GROWTH REGULATORY PATHWAYS IN VASCULAR ANOMALIES(website)
  • H3AFRICA KIDNEY DISEASE RESEARCH NETWORK (website)
  • HETEROTOPIC BONE FROM STEM CELLS IN PERIPHERAL NERVES RELEASED BY NEUROGENIC INFL(website)
  • HIGH-FAT DIET RESCUES LETHALITY OF HOMOZYGOUS KNOCK-IN R155H VCP MYOPATHIC MICE(website)
  • HOMEOSTASIS AND REPAIR IN THE MARFAN AORTA(website)
  • IMAGING OF FAILED REGENERATION IN MUSCLES OF MUSCULAR DYSTROPHY PATIENTS(website)
  • IMPROVED UNDERSTANDING OF THE BIOLOGY AND USE OF THE TNF INHIBITION IN JIA(website)
  • INFLAMMASOME FUNCTION AND SJIA(website)
  • INTERPLAY BETWEEN TYPE I IFN AND TGF-BETA SIGNALING IN SYSTEMIC SCLEROSIS(website)
  • LOCAL INTRAVASCULAR DELIVERY OF FOLLISTATIN GENE THERAPY FOR MUSCULAR DYSTROPHY(website)
  • MACROPHAGE ACTIVATION SYNDROME BIOMARKERS IN SYSTEMIC JUVENILE IDIOPATHIC ART(website)
  • MAPPING MODIFIERS OF CARDIOMYOPATHY UN MUSCULAR DYSTROPHY(website)
  • MECHANISMS UNDERLYING ADVERSE CUTANEOUS EFFECTS OF THE ANTI-CANCER DRUG.(website)
  • MOLECULAR IMAGING FOR DETECTION AND TREATMENT MONITORING OF ARTHRITIS(website)
  • MUSCLE HISTOLOGY AND CLINICAL REPOSITORY CORE(website)
  • MUSCULAR DYSTROPHY THERAPY BY INCREASED ANGIOGENESIS(website)
  • OPTIMIZATION OF HUMAN IPS- BASED CELL THERAPY FOR MUSCULAR DYSTROPHIES(website)
  • OPTIMIZING NORMAL COLLAGEN REPLACEMENT IN OSTEOGENESIS IMPERFECTA(website)
  • PATHOBIOLOGY OF PBMC GENE EXPRESSION SIGNATURES IN POLYARTICULAR AND OLIGOARTICUL(website)
  • PATHOBIOLOGY OF THE MONOMYELOCYTOID CELL GENE EXPRESSION SIGNATURE IN SYSTEMICJIA(website)
  • PATHOGENESIS AND THERAPY OF ICHTHYOSIS IN DISORDERS OF LIPID METABOLISM (website)
  • PATHOGENESIS OF MUSCULAR DYSTROPHIES(website)
  • PATHOGENIC ROLE OF VALOSIN-CONTAINING PROTEIN (VCP) IN IBMPFD(website)
  • PLANNING A MULTICENTER TRIAL OF PDE5A INHIBITION FOR DUCHENNE MUSCULAR DYSTROPHY(website)
  • PROJECT 1 BIOMARKERS OF DISEASE ACTIVITY AND PROGRESSION IN SYSTEMIC SCLEROSIS(website)
  • PROMOTING REGENERATION IN MUSCULAR DYSTROPHY WITH ADIPOSE DERIVED STEM CELLS (website)
  • REDUCING SKELETAL MUSCLE FIBROSIS IN DMD WITH AAV-DELIVERED MIR-29(website)
  • REGULATION OF DERMAL FIBROBLASTS IN SKIN REGENERATION AND HEALING(website)
  • RETINOIC ACID MODULATION FOR SCLERODERMA(website)
  • ROLE OF THE LEPRECAN GENES IN SKELETAL FORMATION(website)
  • ROLE OF THE MATRIX METALLOPROTEINASE IN PEMPHIGUS AUTOANTIBODY-MEDIATED EPIDERMAL(website)
  • ROLE OF ZNF9 IN PATHOGENESIS OF MYOTONIC DYSTROPHY TYPE 2 (DM2)(website)
  • ROLES OF RNA HELICASE AND RIBOSOMAL BIOGENESIS IN NORMAL AND DISEASED MUSCLE(website)
  • SACROILIITIS IN EARLY ERA(website)
  • SCLEROSTIN ANTIBODY THERAPY FOR TREATMENT OF OSTEOGENESIS IMPERFECTA(website)
  • SOLUBLE MOTOGENS AND CHEMOATTRACTANTS FROM DAMAGED MUSCLE(website)
  • SPECTROSCOPIC PROBES OF THE MUSCLE CYTOSKELETON(website)
  • SYK BLOCKADE IN BULLOUS SKIN DISEASES(website)
  • SYSTEMS BIOLOGY OF TUMOR PROGRESSION AND DRUG RESISTANCE (website)
  • TARGETING JAK3 IN THE TREATMENT OF AUTOIMMUNE DISEASE(website)
  • TARGETING MEMBRANE REPAIR IN MUSCULAR DYSTROPHY (website)
  • TELOMERE EXTENSION USING NUCLEOSIDE-MODIFIED MRNA AND EXOSOMES AS A NOVEL THERAPE(website)
  • THE FUNCTION OF PEDF IN RECESSIVE OSTEOGENESIS IMPERFECTA(website)
  • THE ROLE OF ER STRESS IN SYSTEMIC SCLERODERMA(website)
  • THE ROLE OF GERMLINE MUTATIONS IN THE RAS/MAPK PATHWAY ON SKELETAL MYOGENESIS(website)
  • THE ROLE OF IFT80 IN BONE FORMATION(website)
  • THE ROLE OF LYSOPHOSPHATIDIC ACID (LPA) AND ITS RECEPTOR, LPA1 IN SCLERODERMA (website)
  • THE ROLE OF PRESENILIN IN HIDRADENITIS SUPPURATIVA(website)
  • THICK AND THIN FILAMENT MUTATIONS THAT CAUSE DISTAL ARTHROGRYPOSIS(website)
  • TRAINING AND EDUCATION CORE(website)

2011

  • 2011 COLLAGEN GORDON RESEARCH CONFERENCES AND GORDON RESEARCH SEMINAR PROGRAM(website)
  • ADVANCED THERAPIES IN JIA: TOWARD PREDICTIVE TREATMENT(website)
  • ANIMAL CARE: SUPPORTING RESEARCH ON PATHOGENESIS AND TREATMENT OF AUTOIMMUNITY(website)
  • ANTISENSE OLIGONUCLEOTIDE TREATMENT FOR MYOTONIC DYSTROPHY (website)
  • ARTIFICIAL SITE-SPECIFIC RNA ENDONUCLEASE AS NEW MYOTONIC DYSTROPHY THERAPEUTICS(website)
  • ASSESSING AND MODULATING THE ROLE OF INFLAMMATION AND FIBROSIS IN THE DYSTROPHIC(website)
  • BECKER MUSCULAR DYSTROPHY: A NATURAL HISTORY STUDY TO PREDICT EFFICACY OF EXON SK(website)
  • BIOMARKER DISCOVERY AND VALIDATION IN A DUCHENNE DYSTROPHY NATURAL HISTORY STUDY(website)
  • BIOMARKERS OF PULMONARY COMPLICATIONS OF SCLERODERMA: THE SSC-PAH AND(website)
  • CALCITONIN FOR TREATING X-LINKED HYPOPHOSPHATEMIA(website)
  • CALCIUM REGULATION IN THE PROGRESSION OF MUSCULAR DYSTROPHY(website)
  • CATHESPIN K RADIOLIGANDS FOR IN VIVO IMAGING(website)
  • CENTER FOR RESEARCH TRANSLATION OF SYSTEMIC EXON-SKIPPING IN MUSCULAR DYSTROPHY (website)
  • CLINICALLY MEANINGFUL OUTCOMES FOR DUCHENNE MUSCULAR DYSTROPHY THERAPEUTIC TRIALS(website)
  • CO_FUND(website)
  • CONFORMATIONAL MEASUREMENTS OF RYR1 USING A SITE-SPECIFIC LABELING METHOD (website)
  • CONNECTIVE TISSUE DISEASES/INFLAMMATORY MYOPATHIES–POLYMYOSITIS/DERMATOMYOSITIS(website)
  • CORE C – LUNG PATHOLOGY CORE(website)
  • CYTOKINE SIGNALING AND PRIMARY IMMUNODEFICIENCY(website)
  • DETERMINANTS OF HEALTH RELATED QUALITY OF LIFE IN CHILDREN WITH JIA(website)
  • DEVELOPMENT OF A PORCINE MODEL OF DUCHENNE MUSCULAR DYSTROPHY(website)
  • DEVELOPMENTAL BASIS OF ANEURYSM IN MARFAN SYNDROME AND THERAPEUTIC IMPLICATION(website)
  • DISCLOSING GENOMIC INCIDENTAL FINDINGS IN A CANCER BIOBANK: AN ELSI EXPERIMENT (website)
  • DOES INCREASING BONE MASS ALSO INCREASE BONE STRENGTH IN MOUSE MODELS OF OI?(website)
  • DYSTROPHIC MOUSE COLONY AND FORCE ASSESSMENT(website)
  • ELECTRICAL IMPEDANCE MYOGRAPHY AND QUANTITATIVE ULTRASOUND IN DUCHENNE MUSCULAR D(website)
  • ETIOLOGY AND THERAPY OF RICKETS IN THE HYP MOUSE MODEL OF XLH(website)
  • EVALUATION AND TREATMENT OF ENTHESITIS-RELATED ARTHRITIS(website)
  • EVALUATION OF A NOVEL ANTI-RESORPTIVE THERAPY FOR OSTEOGENESIS IMPERFECTA(website)
  • GENE THERAPY IN GOLDEN RETRIEVER MUSCULAR DYSTROPHY MODEL(website)
  • GENETIC METABOLIC MYOPATHIES–PHOSPHOFRUCTOKINASE/ACID MALTASE DEFICIENCY(website)
  • GENOMICS/BIOINFORMATICS CORE(website)
  • HIGHTHROUGHPUT SCREENING CORE(website)
  • HISTOLOGY AND CLINICAL REPOSITORY CORE(website)
  • HOMEOSTASIS AND REPAIR IN THE MARFAN AORTA(website)
  • IDENTIFICATION OF A NOVEL POPULATION IN THE ADULT BONE MARROW(website)
  • IDENTIFYING THE GENE FOR SCLERODERMA IN TSK/2 MICE THAT MODEL HUMAN SSC SUBSETS (website)
  • IMAGING AND ANTIBODIES(website)
  • IMAGING OF FAILED REGENERATEDION IN MUSCLES OF MUSCULAR DYSTROPHY PATIENTS(website)
  • IMMUNOPATHOGEN AUTOIMMUNE INFLAMMATORY MYOPATHIES–POLYMYOSITIS/DERMATOMYOSITIS(website)
  • IMPROVED UNDERSTANDING OF THE BIOLOGY AND USE OF THE TNF INHIBITION IN JIA(website)
  • INCORPORATION OF GENOMIC SEQUENCING INTO PEDIATRIC CANCER CARE (website)
  • INVESTIGATION OF SULF REGULATION ON THE NONCANONICAL WNT SIGNALING PATHWAY(website)
  • INVESTIGATION OF SULF REGULATION ON THE NONCANONICAL WNT SIGNALING PATHWAY (website)
  • LYMPHANGIOLEIOMYOMATOSIS (LAM) REGISTRY (website)
  • MAPPING MODIFIERS OF CARDIOMYOPATHY UN MUSCULAR DYSTROPHY(website)
  • MECHANISMS OF GENETIC REVERSION IN ICHTHYOSIS WITH CONFETTI(website)
  • MECHANISMS OF MITOCHONDRIAL MYOPATHY (website)
  • MG53-MEDIATED MEMBRANE REPAIR IN MUSCLE PHYSIOLOGY AND DISEASE(website)
  • MICROARRAY-BASED BIOMARKERS IN JUVENILE IDIOPATHIC ARTHRITIS(website)
  • MODEL OF HUMAN DISC REGENERATION IN THE SPECTRUM OF DEGENERATIVE DISC DISEASE (website)
  • MODULATION OF MUSCLE REGENERATION BY GROWTH FACTORS(website)
  • MOLECULAR DIAGNOSTICS AND CELL BANKING(website)
  • MOLECULAR MARKERS FOR PROGRESSION OF PULMONARY FIBROSIS IN SYSTEMIC SCLEROSIS (website)
  • MOLECULAR MECHANISMS OF MUSCLE GROWTH AND WASTING IN HEALTH AND DISEASE(website)
  • MOLECULAR MECHANISMS OF MYOFIBRIL ASSEMBLY AND FUNCTION(website)
  • MUNC13-4 GENE POLYMORPHISMS IN MACROPHAGE ACTIVATION SYNDROME AND SYSTEMIC JUVENI(website)
  • MUSCLE HISTOLOGY AND CLINICAL REPOSITORY CORE(website)
  • MUSCLE PHENOTYPING AND IMAGING CORE(website)
  • MUSCLE-SPECIFIC BASIS OF OPMD(website)
  • NATIONAL CANINE MUSCULAR DYSTROPHY CORE(website)
  • NCRM PILOT GRANT FUNDING(website)
  • NODAL POINTS IN MARFAN SYNDROME PROGRESSION(website)
  • NOVEL THERAPEUTIC TARGETS AND/OR PROGNOSTIC MARKERS IN MARFAN SYNDROME(website)
  • OPTIMIZATION OF AO DRUGS 45; 51 & 53(website)
  • PATHOBIOLOGY OF THE MONOMYELOCYTOID CELL GENE EXPRESSION SIGNATURE IN SYSTEMICJIA(website)
  • PATHOGENESIS AND TREATMENT OF NOMID; DIRA AND OTHER AUTOINFLAMMATORY DISEASES(website)
  • PATHOGENESIS OF BEHCET’S DISEASE AND STILL’S DISEASE(website)
  • PHYSIOLOGICAL ASSESSMENT CORE(website)
  • PROGRAMMED CELL DEATH IN REGULATION OF AUTOIMMUNITY(website)
  • REGULATION OF APOPTOSIS IN OSTEOBLASTS BY RUNX2 AND NFKB(website)
  • REGULATION OF OSTEOBLAST FUNCTION BY MEGAKARYOCYTES: KEY SIGNALING PROTEINS(website)
  • REGULATION OF OSTEOCLAST BIOLOGY BY ANION EXCHANGER SLC4A2 IN MOUSE AND HUMAN SYS(website)
  • REGULATION OF SUBCELLULAR ORGANIZATION IN SKELETAL MUSCLE(website)
  • RNA FIDELITY AND PROTEIN FUNCTION OF BECKER-LIKE IN-FRAME DELETIONS(website)
  • ROLE OF FN14 IN RNA TOXICITY(website)
  • ROLE OF THE GIANT PROTEIN TITIN IN SKELETAL MUSCLE STRUCTURE AND FUNCTION (website)
  • RUNX2 AND AXIN2 INTERACTIONS DURING BONE FORMATION(website)
  • SAFETY AND FEASIBILITY STUDY OF TRANSVENOUS LIMB PERFUSION WITH NORMAL SALINE IN(website)
  • SEGMENTAL CHROMOSOME SHARING IN AFFECTED RELATIVES WITH JUVENILE ARTHRITIS(website)
  • SKELETAL GENETIC PATHWAYS OF NOTCH AND P53 IN THE PATHOGENESIS OF OSTEOSARCOMA(website)
  • STRUCTURAL BIOLOGY OF AMYLOID AND AMYLOID-LIKE PROTEINS(website)
  • TARGETING FIBROCYTES IN DUCHENNE MUSCULAR DYSTROPHY(website)
  • TARGETING THROMBOSPONDIN 1 IN BONE RESORPTION(website)
  • THE EFFECTS OF CFTR DYSFUNCTION ON BONE FORMATION(website)
  • THE ROLE OF FHL1 IN EMERY-DREIFUSS AND REDUCING BODY MYOPATHIES(website)
  • THE ROLE OF TWIST FAMILY BHLH FACTORS IN LIMB MORPHOGENESIS(website)
  • TISSUE DISTRIBUTION FOR RARE DISEASE RESEARCH (website)
  • TRAINING AND EDUCATION CORE(website)
  • TRANSLATIONAL IMMUNOLOGY RESEARCH: A SUPPORT FOR CLINICAL IMMUNOLOGICAL RESEARCH(website)
  • TRANSLATIONAL OPPORTUNITIES FOR THE HERITABLE DISORDERS OF CONNECTIVE TISSUE(website)
  • VASCULAR DELIVERY OF ALPHA-SARCOGLYCAN FOR LGMD2D(website)
  • WEBSMART: EFFICACY OF WEB-BASED PAIN SELF-MANAGEMENT FOR ADOLESCENTS WITH JIA(website)

2010

  • A role for IL-1 in SJIA monocyte phenotypes: A RAPPORT ancillary study (website)
  • Adherence-strong for juvenile arthritis (website)
  • Antiphospholipid antibodies and lupus: new molecular targets for treatment (website)
  • ATF4 and Osteoclastogenesis (website)
  • Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle (website)
  • Calcium and oxidative stress in muscular dystrophy (website)
  • CF Bone Disease: Convergence of CFTR and PTH Signaling (website)
  • Clonal Isogenic and Immortalized FSHD Myoblasts with or without D4Z4 Contraction (website)
  • Comparison of Bisphosphonate Treatment Regimens on Skeletal Growth & Biomechanics (website)
  • Consequences of Mutant COMP Expression and Therapeutic Approaches in Transgenic M (website)
  • Cx26 mutations in syndromic deafness linked to skin disease (website)
  • Delivery of Soluble FGFR3 as a Treatment for Achondroplasia (website)
  • Drosophila as a model for Emery-Dreifuss muscular dystrophy (website)
  • Dysferlin regulation of acetylcholine signaling at the C. elegans NMJ (website)
  • Genetic & immunologic etiology of chronic recurrent multifocal osteomyelitis-CRMO (website)
  • GFI-1 and Osteoblast Suppression in Multiple Myeloma (website)
  • Hematopoietic Stem Cell Transplantation in Osteogenesis Imperfecta (website)
  • Imaging of failed Regeneratedion in muscles of muscular dystrophy patients (website)
  • Intra-arterial delivery of skeletal muscle stem cells (website)
  • Intracellular calcium leak and muscle function (website)
  • Joint Contractures in Golden Retriever Muscular Dystrophy: A Model for Duchenne M (website)
  • Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy (website)
  • Mechanisms and efficacy of myostatin inhibition in myotubular myopathy (website)
  • Mechanisms of Force Loss in Injured and Dystrophic Skeletal Muscle (website)
  • Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients (website)
  • Mechanotransduction Approach to Improve Bone Quality in Osteogenesis Imperfecta (website)
  • Messenger RNA stability in myotonic dystrophy (website)
  • Modulating tolerance in a spontaneous mouse model of autoimmune vitiligo (website)
  • Modulation of Muscle Regenerationby Growth Factors (website)
  • Molecular and cellular mechanisms of heterotopic ossification (website)
  • Molecular Pathways Regulated By DUX4, an FSHD-Associated Gene (website)
  • Natural history of bone disease and the impact of growth hormone treatment in MPS (website)
  • Pathogenesis of autoimmune endocarditis: roles for Fc receptors and integrins? (website)
  • Pathogenesis of Monoclonal Gammopathy Bone Disease (website)
  • PKA-Wnt Crosstalk in Bone is Mediated by beta-Catenin Nuclear Complex Formation (website)
  • Potassium channels in myotonic dystrophy type 1 (website)
  • Preclinical Testing of Integrin Enhancing Molecules for the Treatment of Muscular (website)
  • Protein Therapeutics for Muscular Dystrophy (website)
  • Role of autoantibody isotype in pemphigus pathogenesis (website)
  • Targeting a Toxic RNA with Small Molecules (website)
  • The Role of IL-17 Axis in Inflammatory Myositis (website)
  • The Role of mu-Crystallin in Facioscapulohumeral Muscular Dystrophy (website)
  • The role of nucleo-cytoskeletal link proteins in skeletal muscle (website)
  • The Role of Protein Turnover in a Drosophila Model of Muscle Atrophy (website)
  • The Role of RECQL4 in Bone Development and Osteosarcoma (website)
  • The role of Spry2 in regulation of bone formation (website)